If drug development is still in pre-clinical stage (meaning it has not been tested on humans yet), a market cap of 21.8 million is too high. Human trials take years to complete. In my opinion, they’ve got a loooong way to go....
Too risky
- Forums
- ASX - By Stock
- NYR
- IPO - Nyrada Inc.
IPO - Nyrada Inc., page-25
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
|
|||||
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.292M |
Open | High | Low | Value | Volume |
5.1¢ | 5.1¢ | 5.1¢ | $10 | 193 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 146824 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 0.042 |
1 | 29440 | 0.034 |
1 | 75000 | 0.032 |
1 | 13000 | 0.031 |
4 | 183333 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 146824 | 2 |
0.053 | 99807 | 1 |
0.055 | 170000 | 1 |
0.057 | 30000 | 1 |
0.058 | 20000 | 1 |
Last trade - 11.00am 16/08/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online